Jiaming Xu Xiao-Lei Gong Huanwen Wu Lin Zhao
10.3389/fonc.2020.582087
Front Oncol
2020 Nov 23;10:582087.
tfe3 anti-vegfr apatinib mammalian target of rapamycin inhibitor perivascular epithelioid cell tumors tyrosine kinase inhibitor
CC BY
https://pubmed.ncbi.nlm.nih.gov/33330059/
Case Reports
PMC7719820
33330059
Case Report: Gastrointestinal PEComa With TFE3 Rearrangement Treated With Anti-VEGFR TKI Apatinib
2020